HOME >> BIOLOGY >> NEWS
Robert S. Langer to present the 2001 Ullyot Public Affairs Lecture

Biomaterials and how they will change our lives

Philadelphia--Robert S. Langer, Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering at the Massachusetts Institute of Technology, has been chosen to deliver the 2001 Ullyot Public Affairs Lecture with a presentation titled "Biomaterials and How They Will Change Our Lives." The lecture, scheduled to take place at the Chemical Heritage Foundation on Thursday, 20 September 2001, will discuss advances in drug delivery that have revolutionized the medical industry. Since joining the MIT faculty in 1977, Langer has specialized in controlled drug delivery and tissue engineering. His discoveries are at the heart of today's multi-billion dollar controlled drug delivery industry and have provided a framework for the emerging technology of tissue engineering. Much of Langer's research has been in biomedical applications of polymers, and his groundbreaking research dispelled the belief that only some sizes of molecules could be delivered slowly.

Langer's later research has led to the development of a number of novel biodegradable polymers with medical applications. One of these resulted in a drug delivery system for the treatment of brain cancer (developed with Dr. Henry Brem of Johns Hopkins University Medical School)-the first FDA-approved treatment for brain cancer in 20 years and the first polymer-based treatment to deliver chemotherapy directly to a tumor site. This treatment has extended the lives of numerous patients and has far fewer side effects than conventional chemotherapy.

Langer has received over eighty major awards. In 1996, he became the only engineer to receive the Gairdner Foundation International Award; fifty-four recipients of this award have subsequently received a Nobel Prize. He received the $500,000 Lemelson-MIT prize, the world's largest prize for invention, in 1998 for being, "one of history's most prolific inventors in medicine," and
'"/>

Contact: Scott P. Lockledge
scottl@chemheritage.org
215-925-2222
Chemical Heritage Foundation
21-Aug-2001


Page: 1 2

Related biology news :

1. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
2. UC Riversides professor Robert Graham elected Fellow of the Soil Science Society of America
3. Robert Horvitz, pioneer in cell death, to be awarded international genetics prize
4. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
5. DFG presents the 2004 MAK and BAT value lists
6. Presidential Recognition Awards presented at the 2004 AIUM Annual Convention
7. National study shows dog and cat allergens are universally present in U.S. homes
8. VIB presents its annual results at BIO2004 in San Francisco
9. White House lauds Physiological Society for mentoring underrepresented minorities in biomedicine
10. AACR awards scholarships to minority and underrepresented scientists
11. Steroid-coated DNA represents new approach to gene delivery

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
Cached News: